Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-12-030772
Filing Date
2012-05-21
Accepted
2012-05-21 08:12:03
Documents
8
Period of Report
2012-06-17
Effectiveness Date
2012-05-21

Document Format Files

Seq Description Document Type Size
1 v313660-def14a.htm DEF 14A 725915
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_protalix.jpg GRAPHIC 4327
4 GRAPHIC spacer.gif GRAPHIC 43
5 GRAPHIC sig_david-aviezer.jpg GRAPHIC 2289
6 GRAPHIC sig_yossi-maimon.jpg GRAPHIC 1366
7 GRAPHIC v313660_pc-pg1.jpg GRAPHIC 306042
8 GRAPHIC v313660_pc-pg2.jpg GRAPHIC 156960
  Complete submission text file 0001144204-12-030772.txt   1377255
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 12857080
SIC: 2836 Biological Products, (No Diagnostic Substances)